Henry Meds vs. a Local Weight Loss Clinic: The Chattanooga Comparison
I’m an emergency and Family Medicine physician in Chattanooga, Tennessee, and founder of Summit Metabolic Health. I read every patient chart personally. This article reports on a topic patients keep asking about — it is education, not an endorsement.
If you’re in Chattanooga weighing Henry Meds against a local weight loss clinic, you’re really asking one question: do you want a national telehealth subscription, or a physician in your own time zone who reads your chart before every dose change? I’m Dr. Paul Miranda. I’m board-certified, I work ER shifts, and I practice telehealth weight-loss medicine from right here in Chattanooga — not from a call center in another state. Henry Meds has never built a chart-review visit into its model, and here’s what that actually costs you.
Henry Meds is a direct-to-consumer telehealth company. You fill out an intake form online, a clinician somewhere in its network reviews it asynchronously, and compounded semaglutide or tirzepatide ships to your door on a flat monthly subscription. That’s the whole model. There is no scheduled visit where a clinician examines you, reassesses your side effects, and decides whether your dose should change. The form is the consult.
That’s not a judgment — it’s a description. A subscription-shipping company and a medical practice are two different businesses wearing similar marketing. Henry Meds is built to move volume through a funnel, the same structure I broke down in Hims Alternatives for Semaglutide: Physician-Led Care in Chattanooga. A clinic is built to have one physician sit with your history across months, not just your signup form on day one.
Henry Meds isn’t unique in this. It’s one version of a pattern that now spans a dozen national DTC brands, all competing on the same two levers: how low can the sticker price go, and how fast can the intake form approve you. Neither lever has anything to do with whether your dose is right for you six weeks from now. A patient searching “Henry Meds vs local weight loss clinic” is usually further along than that — they’ve already had the subscription experience somewhere, and they’re asking what a physician relationship actually adds. The answer isn’t abstract. It’s the visit that doesn’t happen on their platform.
Henry Meds charges $297 to $399 a month, flat, regardless of dose. You pay the same price on your starting dose as you do months later on a higher one. That flat rate isn’t pegged to what the medication actually costs to compound at your dose — it’s a subscription price.
Summit runs $135 to $225 a month for physician-led compounded care, priced to the medication and the dose, not to a subscription tier. I worked through a near-identical gap in Ro vs. Compounded Semaglutide in Chattanooga: What You Actually Pay, and the same math applies here: a flat DTC rate looks simple until the day the company’s sourcing or pricing model shifts and your bill moves with it, not with your care.
The honest caveat: cheaper isn’t automatically better, and I’m not telling you to chase the lowest number. I’m telling you to ask what the price is actually buying. At Henry Meds, it’s buying shipping and an asynchronous form review. At Summit, it’s buying a physician who adjusts your plan with you.
The clinical trials behind these medications were not run on a flat-rate shipping schedule. STEP 1 (NEJM, 2021) got patients to an average 14.9% body weight loss on semaglutide using a structured dose-titration protocol, with a clinician reassessing at every step-up. SURMOUNT-1 (NEJM, 2022) got patients up to 20.9% weight loss on tirzepatide using the same kind of staged escalation. In both trials, the step-up point is where a clinician checked in — not where a form auto-advanced.
That reassessment point is exactly where GI side effects and cardiovascular risk need a real evaluation, not an async submission. At Summit, I build every dose change around that same principle: slow, custom escalation rather than the fastest schedule the label allows, a paced 1 to 1.5 pounds a week, a dose hold every 25 pounds lost, and a slow taper once you’re at goal rather than a cliff. I covered why that structure beats the checkbox-intake pattern common across telehealth-mill models in Why Physician-Supervised Weight Loss Beats DIY and Telehealth-Mill GLP-1 — Henry Meds’ flat-rate form is that same pattern wearing a different logo.
Henry Meds sources its compounded GLP-1s through 503B outsourcing facilities — the large-batch compounding pharmacies currently facing a pending FDA rule change on what they’re permitted to compound and under what conditions. Industry competitive data flags Henry Meds as carrying the highest exposure of any named national DTC player to that pending rule, specifically because its entire supply chain runs through that one regulatory door.
If that rule tightens, the pattern is predictable: supply disruption, a sudden pricing shift, or a forced product swap — the same kind of abrupt change Ro’s customers absorbed when Ro exited compounded semaglutide and pushed everyone onto branded pricing overnight. A subscription company with no clinic relationship behind it has no fallback to offer you when that happens. You get an email telling you what changed, after it already changed.
A local clinic has the same regulatory exposure on the compounding side — nobody using a 503B pharmacy is exempt from a federal rule change. The difference is what happens next. At Summit, a sourcing disruption is a conversation with your physician about what we switch to and why, not a mass notice to a subscriber list with no clinician attached to explain it. The rule itself doesn’t discriminate by business model. Your experience of it will.
A local, physician-led visit gives you continuity a national platform isn’t built to provide. I personally review every chart before a patient starts semaglutide or tirzepatide at Summit — not a questionnaire routed through software, not whichever clinician is on queue that week. When your dose needs to change, or a side effect shows up, you’re talking to the same physician who started your plan, in the same time zone, not restarting the conversation with a new name every time you message.
That’s the difference between a company managing a subscription and a physician managing a patient.
Before you commit to Henry Meds, a local clinic, or anywhere else, ask:
– Does my dose change require a real reassessment, or does the form just advance on a calendar? – Is my price tied to my dose, or to a subscription tier that stays flat no matter what I’m taking? – Who do I actually reach when a side effect shows up — the same clinician, or a new name in a queue? – Where does my medication come from, and how exposed is that supply chain to a pending compounding rule? – Is there an exit plan built in for when I reach goal weight, or does the subscription just keep billing?
Run Henry Meds and any local option you’re considering through those five questions before you sign up for either. You can read more of what I’ve written about telehealth weight-loss platforms on the Summit blog, including the cost math behind compounded pricing and the pattern behind most DTC intake flows.
Weight loss medication is not a product you subscribe to — it’s a plan a physician manages with you, dose by dose, until you’re at goal and off it. That’s the plan I build with every patient at Summit.
Ready to start? Apply at summitmetabolichealth.com/apply.
This post is for educational purposes and does not replace individualized medical care. Group trial averages are not a promise about your results.
